These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8284489)

  • 1. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2.
    Loftager MK; Eriksen L; Aasted B; Nielsen R
    Res Vet Sci; 1993 Nov; 55(3):281-6. PubMed ID: 8284489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.
    Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K
    Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():1611-4. PubMed ID: 7502867
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.
    Hensel A; Delventhal S; Windt H; Stockhofe-Zurwieden N; Pabst R; Petzoldt K
    Adv Exp Med Biol; 1995; 371B():803-6. PubMed ID: 7502901
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and serum IgA antibodies in pigs following infection with Actinobacillus pleuropneumoniae.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():935-8. PubMed ID: 7502930
    [No Abstract]   [Full Text] [Related]  

  • 7. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Actinobacillus pleuropneumoniae serotype 2 in mucosal secretions and sera of infected pigs as demonstrated by an enzyme-linked immunosorbent assay.
    Loftager MK; Eriksen L; Nielsen R
    Res Vet Sci; 1993 Jan; 54(1):57-62. PubMed ID: 8434149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae.
    Appleyard GD; Furesz SE; Wilkie BN
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):221-8. PubMed ID: 12007888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses.
    Katinger A; Lubitz W; Szostak MP; Stadler M; Klein R; Indra A; Huter V; Hensel A
    J Biotechnol; 1999 Aug; 73(2-3):251-60. PubMed ID: 10486934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model.
    Park J; Seo KW; Kim SH; Lee HY; Kim B; Lim CW; Kim JH; Yoo HS; Jang YS
    Vet Microbiol; 2015 May; 177(1-2):142-53. PubMed ID: 25818577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs.
    Rioux S; Girard C; Dubreuil JD; Jacques M
    Res Vet Sci; 1998; 65(2):165-7. PubMed ID: 9839897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of polyvalent immunity against Actinobacillus pleuropneumoniae in an experimental rat model].
    Herrera L; Montiel E; Rosales ME; Bárcenas G; Lara AV; Montaraz JA
    Rev Latinoam Microbiol; 1995; 37(2):147-52. PubMed ID: 8552874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
    Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.
    Bossé JT; Johnson RP; Nemec M; Rosendal S
    Infect Immun; 1992 Feb; 60(2):479-84. PubMed ID: 1730479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
    Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
    Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of a protective Actinobacillus pleuropneumoniae antigen during the course of infection.
    Hennig I; Teutenberg-Riedel B; Gerlach GF
    Microb Pathog; 1999 Feb; 26(2):53-63. PubMed ID: 10090852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.